SCP & CO Healthcare Acquisition Company Warrant
SHACW
SHACW was delisted on the 8th of December, 2022.
54 hedge funds and large institutions have $4.58M invested in SCP & CO Healthcare Acquisition Company Warrant in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 54 → 54 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
38% less capital invested
Capital invested by funds: $7.38M → $4.58M (-$2.81M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$193K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$38.5K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$19.3K |
| 4 |
QGA
Q Global Advisors
Fort Worth,
Texas
|
+$17.9K |
| 5 |
Parallax Volatility Advisers
San Francisco,
California
|
+$17.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$477K |
| 2 |
Blackstone Inc
New York
|
-$110K |
| 3 |
RA
Ramius Advisors
New York
|
-$107K |
| 4 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$42K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$32.2K |
SHACW Hedge Fund Activity: Q1 2022 in Review
54 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in SCP & CO Healthcare Acquisition Company Warrant (SHACW) for Q1 2022, worth a combined $4.58M — down 38% from $7.38M a quarter earlier.
Fund positioning in SHACW was balanced in Q1 2022: 5 funds opened new positions, 5 closed out, 6 added to existing stakes and 7 trimmed.
The largest buyer was Aristeia Capital, opening a new position worth an estimated $193K. The largest seller was UBS O'Connor, exiting entirely with an estimated $477K sold.
- 54 institutional investors held SCP & CO Healthcare Acquisition Company Warrant (SHACW) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $4.58M of SCP & CO Healthcare Acquisition Company Warrant stock for Q1 2022, down 38% quarter-over-quarter.
- 5 funds opened new SCP & CO Healthcare Acquisition Company Warrant positions in Q1 2022 and 5 closed out, a net change of 0 holders.
- The largest SCP & CO Healthcare Acquisition Company Warrant buyer in Q1 2022 was Aristeia Capital, an estimated $193K added.
- The largest SCP & CO Healthcare Acquisition Company Warrant seller in Q1 2022 was UBS O'Connor, an estimated $477K sold.
Based on aggregated 13F filings for Q1 2022.